Wiremap
Portfolio Growth Intelligence Find My Constraint →
Portfolio Growth Intelligence
For Investors, Portfolio Company Assessment, LiveWire Inc.

Why is the capital not
translating into faster growth?

A portfolio-level commercial assessment identifying the constraints limiting growth velocity, the capital allocation recommendations, and the board discussion priorities for a B2B SaaS portfolio company at Series A.

Stage
Series A · $2.4M ARR
Assessment
Portfolio Growth Intelligence
Board Priority
VP Sales hire timing
Wiremap, A LiveWire Inc. Service, wiremap.co
amulya@wiremap.co
Portfolio Intelligence
Portfolio-level assessment

Company overview and commercial health.

This assessment covers the commercial health of a B2B SaaS portfolio company at Series A, focusing on the constraints limiting growth velocity and the capital efficiency of the current commercial motion.

ARR
$2.4M
NRR
107%
Sales Cycle
4.2 mo
Founder Dep.
High
Primary growth constraint
Founder dependency limiting scalability. Every deal requires founder involvement. VP Sales interview process beginning without a documented motion.
Board discussion priority
Delay the VP Sales hire by 60 days. Use those 60 days to document the motion. A VP Sales hired with a playbook generates revenue in month 4. A VP Sales hired without one generates questions until month 9.
Capital allocation recommendation
Hold the VP Sales budget for 60 days. Invest 30 of those days in motion documentation. The documentation is the highest-ROI commercial investment available right now at zero additional cost.
Constraint Journey
Wiremap · Commercial Assessment
The Constraint Journey
Investor Portfolio · Read this before the detailed findings.
This is the entire story, compressed to one page.
Portfolio State
Multiple portfolio companies growing. Some stalling. Intervention timing unclear.
Portfolio Constraint
Commercial risks invisible in standard reporting. GTM weaknesses masked by founder optimism.
Value Leakage
2-3 portfolio companies heading toward down rounds or stalled growth without visible warning signals.
Intervention
Systematic commercial assessment across portfolio. Early warning on constraint before metrics show it.
Portfolio Uplift
Intervention capital deployed to highest-leverage companies. Board conversations sharper.
Return Enhancement
Portfolio companies exit stronger. Down rounds avoided. Fund returns improve.
The pages that follow provide the evidence, root cause analysis, and recommended actions behind this journey.
This visualization is a map. The report is the territory.
Investor Intelligence
Commercial readiness indicators

Five dimensions assessed. Three require board attention before the next capital deployment.

These indicators are designed for investor review and board discussion. They translate commercial assessment findings into capital allocation and hiring decision guidance.

8.2
Product strength
NRR and expansion data confirm product delivers value
5.4
Motion repeatability
Closes happen but depend on founder not on process
3.1
Hire readiness
Motion undocumented. VP Sales hire would be premature.
6.0
ICP precision
ICP defined. Trigger event not embedded in targeting.
7.5
Series B readiness
Strong with 90-day motion documentation. Weak without it.
Board recommendations
1
Delay VP Sales hire, approve the 60-day motion documentation sprint
The assessment identifies this as the single decision with the highest commercial impact available at this portfolio company right now. At the next board meeting, approve a 60-day delay to the VP Sales hire timeline, with a specific deliverable: a documented sales playbook covering ICP definition, qualification criteria, objection handling, and the repeatable deal structure. This document changes the VP Sales hire from a risk into an investment.
2
Request the trigger event analysis from the founder at the next check-in
The assessment identified that the ICP is defined by company type but not by the specific moment of urgency that drives purchase. Ask the founder one question at the next check-in: of the last five deals that closed, what specific event was happening at each of those companies at the time of purchase? The answer to that question is the trigger event that the outreach should be finding, not just the industry and size profile.
Constraint Map
Commercial constraint mapping

Three constraints identified.

The primary constraint is the root cause. The secondary and emerging constraints are amplified by it. Resolving the primary typically reduces the severity of both others.

Primary
Founder Dependency
Every deal has required founder involvement from first contact to close for 18 months. The commercial advantage is the founder relationship and credibility, not a documented process. This is a structural ceiling on growth velocity.
Secondary
Hiring Before Readiness
VP Sales hire is planned for next quarter. Hiring into an undocumented motion produces a VP Sales who spends 9 to 12 months trying to understand what the founder does rather than executing a defined process.
Emerging
ICP Ambiguity
ICP defined by industry and size. Trigger event absent. The specific moment that creates urgency to purchase has not been identified or embedded in targeting, making outreach conversion dependent on founder relationship rather than message relevance.
Intelligence Confidence
Why we believe this

Intelligence confidence by finding.

Each finding is assigned a confidence level based on the strength of evidence across all five intelligence layers.

FindingConfidenceBasis for this assessment
Motion entirely founder-dependent confirmedHigh ConfidenceIntake data shows zero deals progressing past discovery without founder involvement in 18 months. Network-sourced deal conversion 28-35% vs outbound 4-6%, confirming advantage is founder relationship not motion quality.
VP Sales hire timing is high riskHigh ConfidenceIntake confirms VP Sales interview process beginning with no documented playbook, ICP criteria, or repeatable qualification framework. This is a textbook premature hire configuration.
Series B readiness conditional on motion documentationMedium ConfidenceCurrent commercial metrics are strong enough for Series B with motion documentation. Without it, Series B investors will identify the founder dependency in diligence and either discount the valuation or require the documentation before close.
Leadership readiness: Founder-led with strong commercial instincts and a track record of closing. The leadership structure is appropriate for current stage. It becomes the primary risk factor if the VP Sales hire is made before the motion is documented. Recommend: 60-day delay on VP Sales hire, motion documentation sprint, then hire.
Potential value created
Motion documentation before VP Sales hire saves $200K to $400K in misaligned hire cost and 9 to 12 months of underperformance. The documentation takes 30 days. The ROI of 30 days of founder time is the most compelling capital allocation argument in this portfolio company right now.
LiveWire Inc. · wiremap.co · amulya@wiremap.co
Data and learning notice: Anonymised findings from this assessment may be used to train Wiremap assessment models and the Wiring pattern library. No identifying information disclosed. wiremap.co/privacy
Your Path Forward
If you execute on the recommendations in this report
Where you are heading.
Month by month.
Investor Portfolio · This is not a projection. It is a trajectory based on the constraint being resolved and the recommendations being executed.
1
30 Days
Priority companies assessed. Constraint map complete.
2
60 Days
Interventions underway in high-risk companies.
3
90 Days
Portfolio health visibility established. Pattern Intelligence Brief delivered.
4
6 Months
At-risk companies stabilised. Raise-ready companies identified.
5
12 Months
Portfolio performing above baseline. Returns trajectory improved.
The report started with
Here is where you are.
The report ends with
Here is what your future looks like if you execute.
Ready to run this for your portfolio?
This is a sample Portfolio Growth Intelligence report. The full version is built around your specific companies, your stage, and your portfolio constraints.
Enquire About Investor → View All Assessments